Inventor
LONG CHAOFENG
CN17 patents
⚠️ This page may combine multiple inventors who share the name “LONG CHAOFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GUANGDONG RAYNOVENT BIOTECH CO LTD
12 patentsUS11535613B2Dec 27, 2022
Crystal form and salt form of pyridoimidazole compound and preparation method therefor
GUANGDONG RAYNOVENT BIOTECH CO LTD6 citations73
US11725009B2Aug 15, 2023
Anti-influenza virus pyrimidine derivative
GUANGDONG RAYNOVENT BIOTECH CO LTD2 citations72
US11136319B2Oct 5, 2021
Anti-influenza virus pyrimidine derivative
GUANGDONG RAYNOVENT BIOTECH CO LTD4 citations72
US10526320B2Jan 7, 2020
Pyrrolidine derivatives as PPAR agonists
GUANGDONG RAYNOVENT BIOTECH CO LTD2 citations72
US10278973B2May 7, 2019
Hydroxyl purine compounds and use thereof
GUANGDONG RAYNOVENT BIOTECH CO LTD2 citations72
US12319692B2Jun 3, 2025
Anti-influenza virus pyrimidine derivatives
GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations62
USRE49128EJul 12, 2022
Hydroxyl purine compounds and applications thereof
GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations62
US10399981B2Sep 3, 2019
Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseases
GUANGDONG RAYNOVENT BIOTECH CO LTD1 citations62
US10654808B2May 19, 2020
Tyrosine kinase inhibitor and pharmaceutical composition comprising same
GUANGDONG RAYNOVENT BIOTECH CO LTD1 citations61
US12252487B2Mar 18, 2025
Dominant salt forms of pyrimidine derivatives, and crystal forms thereof
GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations46
US10766862B2Sep 8, 2020
Crystal form and salt form of and preparation method for tyrosine kinase inhibitor
GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations41
US10618898B2Apr 14, 2020
Hydroxyl purine compounds and use thereof
GUANGDONG RAYNOVENT BIOTECH CO LTD0 citations38
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD
5 patentsUS9938292B2Apr 10, 2018
Quinoline derivatives as SMO inhibitors
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD19 citations83
US11008292B2May 18, 2021
FGFR4 inhibitor and preparation method and use thereof
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD1 citations60
US10098885B2Oct 16, 2018
Hydroxyl purine compounds and applications thereof
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD0 citations51
US11440903B2Sep 13, 2022
Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD0 citations50
US10532053B2Jan 14, 2020
Histone deacetylase inhibitor, and preparation method and use thereof
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD0 citations36